Integrated miRNA-mRNA Analysis Revealing the Potential Roles of miRNAs in Chordomas

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Long, Cheng ^a   Jiang, Liang ^a   Wei, Feng ^a   Ma, Chuan ^a   Zhou, Hua ^a   Yang, Shaomin ^b   Liu, Xiaoguang ^a   Liu, Zhongjun ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 149 3P; MICRORNA 1908; MICRORNA 2861; MICRORNA 3185; MICRORNA 663A; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIFICATION; CHORDOMA; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; NOTOCHORD; OSSIFICATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

CHORDOMA; CLUSTER ANALYSIS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; NOTOCHORD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84879476159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066676     Document Type: Article

References (48)

1. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, et al. (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13: e69-76.
2. Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, et al. (2001) Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32: 203-211.
3. Bruderlein S, Sommer JB, Meltzer PS, Li S, Osada T, et al. (2010) Molecular characterization of putative chordoma cell lines. Sarcoma 2010: 630129.
4. Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, et al. (2007) Chordoma: the nonsarcoma primary bone tumor. Oncologist 12: 1344-1350.
5. Deniz ML, Kilic T, Almaata I, Kurtkaya O, Sav A, et al. (2002) Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 51: 753-760; discussion 760.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
8. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, et al. (2011) Toward the blood-borne miRNome of human diseases. Nat Methods 8: 841-843.
9. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M, (2012) microRNAs in cancer management. Lancet Oncol 13: e249-258.
10. Duan Z, Choy E, Nielsen GP, Rosenberg A, Iafrate J, et al. (2010) Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res 28: 746-752.
11. Rosenberg AE, Brown GA, Bhan AK, Lee JM, (1994) Chondroid chordoma-a variant of chordoma. A morphologic and immunohistochemical study. Am J Clin Pathol 101: 36-41.
12. Miettinen M, (1984) Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis. Arch Pathol Lab Med 108: 891-892.
13. Meis JM, Giraldo AA, (1988) Chordoma. An immunohistochemical study of 20 cases. Arch Pathol Lab Med 112: 553-556.
14. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, et al. (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209: 157-165.
15. Wright GW, Simon RM, (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19: 2448-2455.
16. Guilmeau S, (2012) Notch signaling and intestinal cancer. Adv Exp Med Biol 727: 272-288.
17. Stockhausen MT, Kristoffersen K, Poulsen HS, (2012) Notch signaling and brain tumors. Adv Exp Med Biol 727: 289-304.
18. Santarpia L, Lippman SM, El-Naggar AK, (2012) Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets 16: 103-119.
19. Tamborini E, Virdis E, Negri T, Orsenigo M, Brich S, et al. (2010) Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Neuro Oncol 12: 776-789.
20. Gui T, Zhou G, Sun Y, Shimokado A, Itoh S, et al. (2012) MicroRNAs that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification. Lab Invest 92: 1250-1259.
21. Li H, Xie H, Liu W, Hu R, Huang B, et al. (2009) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119: 3666-3677.
22. Hu R, Liu W, Li H, Yang L, Chen C, et al. (2011) A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem 286: 12328-12339.
23. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
24. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-1049.
25. Zhou H, Chen CB, Lan J, Liu C, Liu XG, et al. (2010) Differential proteomic profiling of chordomas and analysis of prognostic factors. J Surg Oncol 102: 720-727.
26. Salisbury JR, (1993) The pathology of the human notochord. J Pathol 171: 253-255.
27. Ho KL, (1985) Ecchordosis physaliphora and chordoma: a comparative ultrastructural study. Clin Neuropathol 4: 77-86.
28. Sommer J, Itani DM, Homlar KC, Keedy VL, Halpern JL, et al. (2010) Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma. J Pathol 220: 608-617.
29. Hunter CJ, Matyas JR, Duncan NA, (2004) Cytomorphology of notochordal and chondrocytic cells from the nucleus pulposus: a species comparison. J Anat 205: 357-362.
30. Trout JJ, Buckwalter JA, Moore KC, Landas SK, (1982) Ultrastructure of the human intervertebral disc. I. Changes in notochordal cells with age. Tissue Cell 14: 359-369.
31. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
32. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
33. Whelan JT, Hollis SE, Cha DS, Asch AS, Lee MH, (2012) Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway. J Cell Physiol 227: 1235-1241.
34. Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, et al. (2012) Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 143: 1660-1669 e1667.
35. Shao H, Huang Q, Liu ZJ, (2012) Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol 65: 191-234.
36. Wang F, Ma YL, Zhang P, Shen TY, Shi CZ, et al. (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 229: 12-24.
37. Li D, Chen P, Li XY, Zhang LY, Xiong W, et al. (2011) Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 15: 673-682.
38. Wang Y, Zheng X, Zhang Z, Zhou J, Zhao G, et al. (2012) MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS One 7: e41693.
39. Jian P, Li ZW, Fang TY, Jian W, Zhuan Z, et al. (2011) Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol 4: 20.
40. Pan J, Hu H, Zhou Z, Sun L, Peng L, et al. (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24: 105-112.
41. Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, et al. (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151: 1068-1082.
42. Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, et al. (2012) Expression of microRNAs in basal cell carcinoma. Br J Dermatol 167: 847-855.
43. Smits P, Lefebvre V, (2003) Sox5 and Sox6 are required for notochord extracellular matrix sheath formation, notochord cell survival and development of the nucleus pulposus of intervertebral discs. Development 130: 1135-1148.
44. Stemple DL, (2005) Structure and function of the notochord: an essential organ for chordate development. Development 132: 2503-2512.
45. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, et al. (2013) Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer 132: 1633-1645.
46. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, et al. (2009) CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer 48: 615-623.
47. Yan B, Zhao JL, (2012) miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein. Apoptosis 17: 717-724.
48. Lisse TS, Chun RF, Rieger S, Adams JS, Hewison M (2013) Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. J Bone Miner Res.